Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9098)
All Articles published online
|
Publishing Process of This Article
|
Jun 21, 2020 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Manganis CD, Chapman RW, Culver EL. Review of primary sclerosing cholangitis with increased IgG4 levels. World J Gastroenterol 2020; 26(23): 3126-3144 [PMID: 32684731 DOI: 10.3748/wjg.v26.i23.3126] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i23/3126.htm |
| Number | Citing Articles |
| 1 |
Abdullgabbar M Hamid, Sultan A Alshoabi, Abdulkhaleq A Binnuhaid, Kamal Alsultan, Amel F Alzain, Abdulmannan M Aman. Primary Sclerosing Cholangitis Associated With Ulcerative Colitis Coexisting With Cholangiocarcinoma: A Case Report. Cureus 2024; doi: 10.7759/cureus.62531
|
| 2 |
Neil C. Khoury, John W. Birk. A Review of IgG4-related Sclerosing Cholangitis (IgG4-SC). Journal of Clinical Gastroenterology 2024; 58(10): 963 doi: 10.1097/MCG.0000000000001984
|
| 3 |
Martin Cornillet, Christina Villard, Fredrik Rorsman, Antonio Molinaro, Emma Nilsson, Stergios Kechagias, Erik von Seth, Annika Bergquist. The Swedish initiative for the study of Primary sclerosing cholangitis (SUPRIM). eClinicalMedicine 2024; 70: 102526 doi: 10.1016/j.eclinm.2024.102526
|
| 4 |
M. Álvarez García, J.C. Álvarez Torices, M.J. Díez Liébana, M.R. de la Fuente Olmos. Thoracoabdominal manifestations of immunoglobulin G4-related disease. Radiología (English Edition) 2023; 65(2): 165 doi: 10.1016/j.rxeng.2022.06.005
|
| 5 |
Mazen Abdalla Rasheed, Vinícius Remus Ballotin, Lucas Goldmann Bigarella, Jonathan Soldera. Post-COVID-19 cholangiopathy: Systematic review. World Journal of Methodology 2023; 13(4): 296-322 doi: 10.5662/wjm.v13.i4.296
Abstract(509) |
Core Tip(436) |
Full Article(HTML)(2387)
|
Full Article with Cover (PDF)-783K(87)
|
Full Article (Word)-231K(31)
|
Audio-195K(2)
|
Peer-Review Report-218K(54)
|
Answering Reviewers-134K(52)
|
Full Article (PDF)-573K(133)
|
Full Article (XML)-233K(48)
|
Times Cited (4)
|
Total Visits (5577)
|
Open
|
| 6 |
Sayan Malakar, Piyush Mishra, Radha Paturu, Ritu Verma, Uday C. Ghoshal. Primary sclerosing cholangitis with high immunoglobulin-G4. Journal of Hepatology 2024; 80(4): e168 doi: 10.1016/j.jhep.2023.09.026
|
| 7 |
Cyriel Y. Ponsioen, David N. Assis, Kirsten M. Boberg, Christopher L. Bowlus, Mark Deneau, Douglas Thorburn, Lars Aabakken, Martti Färkkilä, Bret Petersen, Christian Rupp, Stefan G. Hübscher. Defining Primary Sclerosing Cholangitis: Results From an International Primary Sclerosing Cholangitis Study Group Consensus Process. Gastroenterology 2021; 161(6): 1764 doi: 10.1053/j.gastro.2021.07.046
|
| 8 |
Adrian C. Bateman, Emma L. Culver. Challenges and pitfalls in the diagnosis of IgG4-related disease. Seminars in Diagnostic Pathology 2024; 41(2): 45 doi: 10.1053/j.semdp.2023.11.005
|
| 9 |
Jixuan Wang, Zhiwen Sun, Jingri Xie, Wanli Ji, Yang Cui, Zongxiong Ai, Guoying Liang. Inflammasome and pyroptosis in autoimmune liver diseases. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1150879
|
| 10 |
Ivan Isaia, Giuseppe Natoli, Michele Colaci, Benedetta Stancanelli, Lorenzo Malatino. Sclerosing cholangitis may mimic radiological pattern of cholangiocarcinoma: Differential diagnosis and review of literature. The American Journal of the Medical Sciences 2022; 364(3): 359 doi: 10.1016/j.amjms.2022.04.016
|
| 11 |
Aalam Sohal, Sanya Kayani, Kris V. Kowdley. Primary Sclerosing Cholangitis. Clinics in Liver Disease 2024; 28(1): 129 doi: 10.1016/j.cld.2023.07.005
|
| 12 |
Ruchika Goel, Chundamannil Eapen Eapen. Recognizing Dysfunctional Innate and Adaptive Immune Responses Contributing to Liver Damage in Patients With Cirrhosis. Journal of Clinical and Experimental Hepatology 2022; 12(3): 993 doi: 10.1016/j.jceh.2021.10.001
|
| 13 |
Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago, Roberto Grassia. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders. World Journal of Hepatology 2021; 13(12): 1828-1849 doi: 10.4254/wjh.v13.i12.1828
|
| 14 |
Florian Fronhoffs, Leona Dold, Marijo Parčina, Arne Schneidewind, Maria Willis, Thomas F. E. Barth, Tobias J. Weismüller, Taotao Zhou, Philipp Lutz, Julian A. Luetkens, Peter Gerlach, Steffen Manekeller, Jörg C. Kalff, Tim O. Vilz, Christian P. Strassburg, Glen Kristiansen. Alveolar Echinococcosis in a Patient with Presumed Autoimmune Hepatitis and Primary Sclerosing Cholangitis: An Unexpected Finding after Liver Transplantation. Pathogens 2023; 12(1): 73 doi: 10.3390/pathogens12010073
|
| 15 |
Aalam Sohal, Kris V. Kowdley. Complete Biochemical Remission With Oral Vancomycin in a Patient With Primary Sclerosing Cholangitis and High Serum Immunoglobulin G4 Levels. ACG Case Reports Journal 2024; 11(1): e01256 doi: 10.14309/crj.0000000000001256
|
| 16 |
Michele S. Barnhill, Channa Jayasekera. Secondary Sclerosing Cholangiopathies. Current Hepatology Reports 2024; 23(1): 145 doi: 10.1007/s11901-024-00646-7
|
| 17 |
Kathleen Möller, Barbara Braden, Emma L. Culver, Christian Jenssen, Ehsan Safai Zadeh, Amjad Alhyari, Christian Görg, André Ignee, Michael Hocke, Yi Dong, Siyu Sun, Siegbert Faiss, Christoph F. Dietrich. Secondary sclerosing cholangitis and IgG4-sclerosing cholangitis – A review of cholangiographic and ultrasound imaging. Endoscopic Ultrasound 2023; 12(2): 181 doi: 10.4103/EUS-D-22-00208
|
| 18 |
M. Álvarez García, J.C. Álvarez Torices, M.J. Díez Liébana, M.R. de la Fuente Olmos. Manifestaciones toracoabdominales de las enfermedades relacionadas con la inmunoglobulina G4. Radiología 2023; 65(2): 165 doi: 10.1016/j.rx.2022.06.002
|
| 19 |
Serena Babboni, Pier Giuseppe Vacca, Ludovica Simonini, Daniele Pezzati, Caterina Martinelli, Francesco Frongillo, Giuseppe Bianco, Emanuele Marciano, Giuseppina Basta, Davide Ghinolfi, Serena Del Turco. Cholangiocyte Organoids: The New Frontier in Regenerative Medicine for the Study and Treatment of Cholangiopathies. Journal of Clinical Medicine 2024; 13(6): 1804 doi: 10.3390/jcm13061804
|
| 20 |
Dalal Sabbahia, Halima Msaaf, Meriem Atrassi, Sara Moukhlis, Nissrine Bennani, Abdelhak Abkari. IgG4 Sclerosing Cholangitis: Entity Rarely Described in Children
. American Journal of Pediatrics 2024; 10(3): 158 doi: 10.11648/j.ajp.20241003.19
|
| 21 |
Henry H. Nguyen, Marvin J. Fritzler, Mark G. Swain. A Review on Biomarkers for the Evaluation of Autoimmune Cholestatic Liver Diseases and Their Overlap Syndromes. Frontiers in Molecular Medicine 2022; 2 doi: 10.3389/fmmed.2022.914505
|
| 22 |
Taotao Zhou, Henrike Lenzen, Leona Dold, Bennet Bündgens, Heiner Wedemeyer, Michael P. Manns, Maria A. Gonzalez‐Carmona, Christian P. Strassburg, Tobias J. Weismüller. Primary sclerosing cholangitis with moderately elevated serum‐IgG4 – characterization and outcome of a distinct variant phenotype. Liver International 2021; 41(12): 2924 doi: 10.1111/liv.15028
|
| 23 |
A. K. Guseva, A. V. Okhlobystin. Clinical Features, Differential Diagnosis and Treatment of IgG<sub>4</sub>-Related Sclerosing Cholangitis. The Russian Archives of Internal Medicine 2024; 14(2): 96 doi: 10.20514/2226-6704-2024-14-2-96-107
|
| 24 |
Daniel E. Radford‐Smith, Emmanuel A. Selvaraj, Rory Peters, Michael Orrell, Jonathan Bolon, Daniel C. Anthony, Michael Pavlides, Kate Lynch, Alessandra Geremia, Adam Bailey, Emma L. Culver, Fay Probert. A novel serum metabolomic panel distinguishes IgG4‐related sclerosing cholangitis from primary sclerosing cholangitis. Liver International 2022; 42(6): 1344 doi: 10.1111/liv.15192
|
| 25 |
O. V. Khlynova, P. V. Kosareva, D. S. Fadeev, L. V. Sivakova, E. I. Samodelkin. The role of B-lymphocytes and plasma cells in the pathogenesis of inflammatory bowel diseases. Experimental and Clinical Gastroenterology 2023; (6): 39 doi: 10.31146/1682-8658-ecg-214-6-39-46
|
| 26 |
Sandra Kalthoff, Caroline Wolniak, Philipp Lutz, Christian P. Strassburg, Bettina Langhans, Leona Dold. Only repeatedly elevated IgG4 levels in primary sclerosing cholangitis may distinguish a particular patient phenotype. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03343-3
|
| 27 |
Taotao Zhou, Florian Fronhoffs, Glen Kristiansen, Leona Dold, Dominik J. Kaczmarek, Christian P. Strassburg, Tobias J. Weismüller. Primary sclerosing cholangitis with IgG4‐positive plasma cells in bile duct biopsies ― Frequency and characterization. Journal of Digestive Diseases 2024; 25(6): 394 doi: 10.1111/1751-2980.13295
|
| 28 |
Zhijie Lv, Li Wu, Yan Lu, Shan Liu, Qiushuang Li. Bibliometric analysis of IgG4-related disease research from 2003 to 2022 based on Web of Science Core Collection Databases. Clinical Rheumatology 2023; 42(1): 15 doi: 10.1007/s10067-022-06377-8
|
| 29 |
Sylvia Drazilova, Eduard Veseliny, Patricia Denisa Lenartova, Dagmar Drazilova, Jakub Gazda, Ivica Grgurevic, Martin Janicko, Peter Jarcuska, Yu-Chen Fan. IgG4-Related Sclerosing Cholangitis: Rarely Diagnosed, but not a Rare Disease. Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/1959832
|
| 30 |
Miroslav Vujasinovic, Karouk Said, Christina Villard, Jennifer Carlsson, Christopher Poli, Patrick Maisonneuve, J.-Matthias Löhr. The Role of Immunoglobulin G4 in Outcomes of Primary Sclerosing Cholangitis. Journal of Clinical Medicine 2023; 13(1): 79 doi: 10.3390/jcm13010079
|
| 31 |
Aalam Sohal, Kris V. Kowdley. Novel preclinical developments of the primary sclerosing cholangitis treatment landscape. Expert Opinion on Investigational Drugs 2024; 33(4): 335 doi: 10.1080/13543784.2024.2330738
|